Andlauer Healthcare Group Inc.
AND.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 470.95M | 474.74M | 478.79M | 478.64M | 477.79M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 470.95M | 474.74M | 478.79M | 478.64M | 477.79M |
| Cost of Revenue | 312.53M | 315.56M | 317.64M | 318.92M | 318.77M |
| Gross Profit | 158.42M | 159.18M | 161.15M | 159.72M | 159.02M |
| SG&A Expenses | 39.94M | 38.87M | 39.18M | 38.89M | 37.92M |
| Depreciation & Amortization | 50.69M | 51.79M | 51.93M | 52.06M | 51.71M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 403.16M | 406.23M | 408.76M | 409.87M | 408.41M |
| Operating Income | 67.79M | 68.52M | 70.03M | 68.77M | 69.39M |
| Income Before Tax | 66.96M | 64.33M | 66.04M | 65.32M | 65.68M |
| Income Tax Expenses | 16.91M | 17.31M | 17.89M | 17.68M | 17.84M |
| Earnings from Continuing Operations | 50.05 | 47.03 | 48.15 | 47.64 | 47.84 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 50.05M | 47.03M | 48.15M | 47.64M | 47.84M |
| EBIT | 67.79M | 68.52M | 70.03M | 68.77M | 69.39M |
| EBITDA | 108.14M | 118.32M | 103.70M | 102.94M | 111.90M |
| EPS Basic | 1.26 | 1.17 | 1.18 | 1.15 | 1.15 |
| Normalized Basic EPS | 1.00 | 1.00 | 1.01 | 0.99 | 0.99 |
| EPS Diluted | 1.25 | 1.15 | 1.16 | 1.13 | 1.13 |
| Normalized Diluted EPS | 0.98 | 0.99 | 0.99 | 0.97 | 0.97 |
| Average Basic Shares Outstanding | 158.98M | 161.13M | 163.13M | 165.62M | 166.43M |
| Average Diluted Shares Outstanding | 161.30M | 163.57M | 166.01M | 168.68M | 169.63M |
| Dividend Per Share | 0.32 | 0.31 | 0.29 | 0.28 | 0.27 |
| Payout Ratio | 24.81% | 25.95% | 24.64% | 24.14% | 23.22% |